Response to intravenous cyclophosphamide treatment in lupus myelopathy

Optimal control analysis and Practical NMPC applied to refrigeration systems.

ISA transactions·2020

Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study.

Neuroepidemiology·2007

[Onset of Behçet's disease as meningoencephalitis and sudden blindness].

Archivos de la Sociedad Espanola de Oftalmologia·2002

Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients.

Lupus·2001

High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus.

Rheumatology (Oxford, England)·1999

Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index.

Lupus·1999

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

The Journal of rheumatology·2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

The Journal of rheumatology·2026

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

The Journal of rheumatology·2026

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

The Journal of rheumatology·2026

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

The Journal of rheumatology·2026

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Cancer management and research·2026

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

HemaSphere·2026

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Blood reviews·2026

Related Experiment Videos

Response to intravenous cyclophosphamide treatment in lupus myelopathy

Related Concept Videos

Optimal control analysis and Practical NMPC applied to refrigeration systems.

Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study.

[Onset of Behçet's disease as meningoencephalitis and sudden blindness].

Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients.

High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus.

Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index.

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Related Experiment Videos

Response to intravenous cyclophosphamide treatment in lupus myelopathy

Related Concept Videos

Related Articles